IMBRUVICA

Generic: IBRUTINIB

Pharmacyclics LLCManufacturer
ORALRoute
IBRUTINIBActive Substance
2013-11-13Original Approval

IMBRUVICA is FDA application NDA205552, sponsored by PHARMACYCLICS LLC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DEATH
8,652 reports
2
OFF LABEL USE
6,069 reports
3
FATIGUE
4,780 reports
4
DIARRHOEA
4,224 reports
5
ATRIAL FIBRILLATION
3,926 reports
6
PNEUMONIA
3,291 reports
7
CONTUSION
2,827 reports
8
INCORRECT DOSE ADMINISTERED
2,779 reports
9
FALL
2,544 reports
10
ASTHENIA
2,378 reports